Cholesterol confers resistance to Apatinib-mediated ferroptosis in gastric cancer
Abstract Background Gastric cancer is the fifth leading cause of cancer-related deaths worldwide. Apatinib is a third-line treatment for gastric cancer. However, the development of resistance significantly limits its efficacy, and effective and safe strategies to overcome Apatinib resistance remain...
Saved in:
| Main Authors: | Zhiwei Li, Chenxin Liu, Minghao Wang, Riqing Wei, Ru Li, Kaihua Huang, Huayuan Liang, Guoxin Li, Liying Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Cell & Bioscience |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13578-025-01435-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacy of apatinib in combination treatment versus apatinib as second-line treatment for advanced gastric cancer
by: Zhang Han, et al.
Published: (2025-04-01) -
Analysis of the correlation between the dose exposure intensity and apatinib in advanced gastric cancer: a retrospective cohort study
by: Xiao Ma, et al.
Published: (2025-02-01) -
Efficacy and safety of apatinib in the second-line treatment of advanced gastric cancer
by: GUO Mengya, CHEN Yue, PENG Weiwei, SHA Huanhuan, FANG Ying, ZHOU Guoren
Published: (2025-01-01) -
The evaluation of the efficacy and safety about apatinib combined with immune checkpoint inhibitors in advanced gastric cancer: a real-world study
by: Peng-Fei Zhu, et al.
Published: (2025-06-01) -
Acetyl-L-carnitine ameliorates atherosclerosis in LDLR−/− mice by modulating cholesterol metabolism through SREBP2-dependent cholesterol biosynthesis
by: Jingci Xing, et al.
Published: (2024-12-01)